Logo image of CVNA

CARVANA CO (CVNA) Stock Fundamental Analysis

USA - NYSE:CVNA - US1468691027 - Common Stock

378.3 USD
+0.24 (+0.06%)
Last: 9/18/2025, 3:58:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CVNA. CVNA was compared to 121 industry peers in the Specialty Retail industry. CVNA has only an average score on both its financial health and profitability. CVNA is valued quite expensive, but it does show an excellent growth. This makes CVNA very considerable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CVNA was profitable.
CVNA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CVNA reported negative net income in multiple years.
In multiple years CVNA reported negative operating cash flow during the last 5 years.
CVNA Yearly Net Income VS EBIT VS OCF VS FCFCVNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

CVNA's Return On Assets of 6.01% is fine compared to the rest of the industry. CVNA outperforms 76.86% of its industry peers.
Looking at the Return On Equity, with a value of 32.54%, CVNA belongs to the top of the industry, outperforming 87.60% of the companies in the same industry.
The Return On Invested Capital of CVNA (16.05%) is better than 86.78% of its industry peers.
Industry RankSector Rank
ROA 6.01%
ROE 32.54%
ROIC 16.05%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVNA Yearly ROA, ROE, ROICCVNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin of CVNA (3.46%) is better than 71.07% of its industry peers.
Looking at the Operating Margin, with a value of 9.23%, CVNA belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
With a Gross Margin value of 21.89%, CVNA is not doing good in the industry: 78.51% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CVNA has grown nicely.
Industry RankSector Rank
OM 9.23%
PM (TTM) 3.46%
GM 21.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
CVNA Yearly Profit, Operating, Gross MarginsCVNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CVNA is creating some value.
The number of shares outstanding for CVNA has been increased compared to 1 year ago.
CVNA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CVNA has an improved debt to assets ratio.
CVNA Yearly Shares OutstandingCVNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CVNA Yearly Total Debt VS Total AssetsCVNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 9.05 indicates that CVNA is not in any danger for bankruptcy at the moment.
CVNA has a better Altman-Z score (9.05) than 96.69% of its industry peers.
CVNA has a debt to FCF ratio of 9.28. This is a negative value and a sign of low solvency as CVNA would need 9.28 years to pay back of all of its debts.
CVNA's Debt to FCF ratio of 9.28 is in line compared to the rest of the industry. CVNA outperforms 57.85% of its industry peers.
A Debt/Equity ratio of 3.12 is on the high side and indicates that CVNA has dependencies on debt financing.
CVNA has a worse Debt to Equity ratio (3.12) than 75.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF 9.28
Altman-Z 9.05
ROIC/WACC1.71
WACC9.38%
CVNA Yearly LT Debt VS Equity VS FCFCVNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 4.00 indicates that CVNA has no problem at all paying its short term obligations.
The Current ratio of CVNA (4.00) is better than 95.04% of its industry peers.
CVNA has a Quick Ratio of 2.58. This indicates that CVNA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.58, CVNA belongs to the best of the industry, outperforming 95.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 2.58
CVNA Yearly Current Assets VS Current LiabilitesCVNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 466.06% over the past year.
The Revenue has grown by 39.48% in the past year. This is a very strong growth!
Measured over the past years, CVNA shows a very strong growth in Revenue. The Revenue has been growing by 28.25% on average per year.
EPS 1Y (TTM)466.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%814.29%
Revenue 1Y (TTM)39.48%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%41.94%

3.2 Future

The Earnings Per Share is expected to grow by 47.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.61% on average over the next years. This is a very strong growth
EPS Next Y212.09%
EPS Next 2Y103.61%
EPS Next 3Y75.66%
EPS Next 5Y47.1%
Revenue Next Year40.36%
Revenue Next 2Y32.54%
Revenue Next 3Y30.32%
Revenue Next 5Y27.61%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CVNA Yearly Revenue VS EstimatesCVNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
CVNA Yearly EPS VS EstimatesCVNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 10 -10

3

4. Valuation

4.1 Price/Earnings Ratio

CVNA is valuated quite expensively with a Price/Earnings ratio of 94.81.
CVNA's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.20. CVNA is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 58.12 indicates a quite expensive valuation of CVNA.
CVNA's Price/Forward Earnings ratio is in line with the industry average.
CVNA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 94.81
Fwd PE 58.12
CVNA Price Earnings VS Forward Price EarningsCVNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CVNA is valued a bit more expensive than 65.29% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CVNA.
Industry RankSector Rank
P/FCF 132.37
EV/EBITDA 47.56
CVNA Per share dataCVNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CVNA's earnings are expected to grow with 75.66% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y103.61%
EPS Next 3Y75.66%

0

5. Dividend

5.1 Amount

No dividends for CVNA!.
Industry RankSector Rank
Dividend Yield N/A

CARVANA CO

NYSE:CVNA (9/18/2025, 3:58:01 PM)

378.3

+0.24 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners91.9%
Inst Owner Change-5.76%
Ins Owners2.79%
Ins Owner Change-3.82%
Market Cap81.41B
Analysts77.93
Price Target414.02 (9.44%)
Short Float %10.17%
Short Ratio5.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.04%
Min EPS beat(2)13.33%
Max EPS beat(2)130.76%
EPS beat(4)4
Avg EPS beat(4)96.22%
Min EPS beat(4)13.33%
Max EPS beat(4)150.09%
EPS beat(8)7
Avg EPS beat(8)105.29%
EPS beat(12)10
Avg EPS beat(12)83.64%
EPS beat(16)10
Avg EPS beat(16)51.94%
Revenue beat(2)2
Avg Revenue beat(2)3.82%
Min Revenue beat(2)3.4%
Max Revenue beat(2)4.24%
Revenue beat(4)4
Avg Revenue beat(4)4.09%
Min Revenue beat(4)3.4%
Max Revenue beat(4)4.94%
Revenue beat(8)6
Avg Revenue beat(8)2.93%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)10
Avg Revenue beat(16)1.15%
PT rev (1m)4.06%
PT rev (3m)41.27%
EPS NQ rev (1m)1.73%
EPS NQ rev (3m)44.21%
EPS NY rev (1m)5.15%
EPS NY rev (3m)6.14%
Revenue NQ rev (1m)1.53%
Revenue NQ rev (3m)17.09%
Revenue NY rev (1m)5.56%
Revenue NY rev (3m)6.31%
Valuation
Industry RankSector Rank
PE 94.81
Fwd PE 58.12
P/S 5
P/FCF 132.37
P/OCF 112.45
P/B 47.06
P/tB 48
EV/EBITDA 47.56
EPS(TTM)3.99
EY1.05%
EPS(NY)6.51
Fwd EY1.72%
FCF(TTM)2.86
FCFY0.76%
OCF(TTM)3.36
OCFY0.89%
SpS75.62
BVpS8.04
TBVpS7.88
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.01%
ROE 32.54%
ROCE 18.9%
ROIC 16.05%
ROICexc 20.89%
ROICexgc 21%
OM 9.23%
PM (TTM) 3.46%
GM 21.89%
FCFM 3.78%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
F-Score7
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF 9.28
Debt/EBITDA 3.01
Cap/Depr 37.85%
Cap/Sales 0.67%
Interest Coverage 6.89
Cash Conversion 40.45%
Profit Quality 109.24%
Current Ratio 4
Quick Ratio 2.58
Altman-Z 9.05
F-Score7
WACC9.38%
ROIC/WACC1.71
Cap/Depr(3y)83.57%
Cap/Depr(5y)253.76%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)466.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%814.29%
EPS Next Y212.09%
EPS Next 2Y103.61%
EPS Next 3Y75.66%
EPS Next 5Y47.1%
Revenue 1Y (TTM)39.48%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%41.94%
Revenue Next Year40.36%
Revenue Next 2Y32.54%
Revenue Next 3Y30.32%
Revenue Next 5Y27.61%
EBIT growth 1Y274.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.61%
EBIT Next 3Y50.43%
EBIT Next 5Y37.48%
FCF growth 1Y203.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.76%
OCF growth 3YN/A
OCF growth 5YN/A